Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revolution Medicines, Inc. (RVMD)  
$79.65 0.02 (0.03%) as of 4:30 Wed 12/31


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 200,590,000
Market Cap: 15.98(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.13 - $81.19
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,304,347
Total Buy Value $0 $0 $0 $59,999,962
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 253,286 419,987 475,274 995,215
Total Sell Value $16,800,500 $24,209,127 $26,393,208 $50,095,506
Total People Sold 5 6 6 8
Total Sell Transactions 17 28 42 100
End Date 2025-10-02 2025-07-01 2024-12-31 2024-01-01

   
Records found: 492
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cislini Jeff General Counsel   •       •      –    2025-12-16 4 AS $76.82 $206,484 D/D (2,688) 47,884 4%     
   Goldsmith Mark A See Remarks   •       •      –    2025-12-16 4 AS $76.82 $1,182,526 D/D (15,394) 232,469 4%     
   Horn Margaret A Chief Operating Officer   •       •      –    2025-12-16 4 AS $76.82 $372,333 D/D (4,847) 141,053 4%     
   Anders Jack Chief Financial Officer   •       •      –    2025-12-16 4 AS $77.09 $239,289 D/D (3,104) 108,065 4%     
   Kelsey Stephen Michael See Remarks   •       •      –    2025-12-16 4 AS $76.82 $418,423 D/D (5,447) 278,600 4%     
   Anders Jack Chief Financial Officer   •       •      –    2025-11-25 4 AS $74.00 $400,932 D/D (5,418) 110,994 6%     
   Anders Jack Chief Financial Officer   •       •      –    2025-11-25 4 OE $17.00 $92,106 D/D 5,418 116,412     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-25 4 AS $75.00 $450,000 I/I (6,000) 67,424 6%     
   Goldsmith Mark A See Remarks   •       •      –    2025-11-25 4 AS $75.08 $4,504,962 D/D (60,000) 247,863 6%     
   Goldsmith Mark A See Remarks   •       •      –    2025-11-25 4 OE $4.09 $245,400 D/D 60,000 307,863     -
   Cislini Jeff General Counsel   •       •      –    2025-11-18 4 AS $70.14 $939,008 D/D (13,388) 50,425 14%     
   Cislini Jeff General Counsel   •       •      –    2025-11-18 4 OE $42.45 $568,321 D/D 13,388 63,813     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-18 4 AS $70.38 $1,407,586 D/D (20,000) 247,863 14%     
   Goldsmith Mark A See Remarks   •       •      –    2025-11-18 4 OE $4.09 $81,800 D/D 20,000 267,863     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-12 4 AS $65.07 $1,301,410 D/D (20,000) 247,863 23%     
   Goldsmith Mark A See Remarks   •       •      –    2025-11-12 4 OE $4.09 $81,800 D/D 20,000 267,863     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-12 4 GA $0.00 $0 I/I 100,000 54,498     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-12 4 GD $0.00 $0 D/D 100,000 247,863     -
   Anders Jack Chief Financial Officer   •       •      –    2025-11-11 4 AS $64.00 $640,000 D/D (10,000) 110,994 26%     
   Anders Jack Chief Financial Officer   •       •      –    2025-11-11 4 OE $17.00 $170,000 D/D 10,000 120,994     -
   Goldsmith Mark A See Remarks   •       •      –    2025-11-07 4 AS $60.31 $1,809,306 D/D (30,000) 347,863 32%     
   Goldsmith Mark A See Remarks   •       •      –    2025-11-07 4 OE $1.12 $44,057 D/D 30,000 377,863     -
   Cislini Jeff General Counsel   •       •      –    2025-10-17 4 AS $55.00 $660,000 D/D (12,000) 50,425 49%     
   Cislini Jeff General Counsel   •       •      –    2025-10-17 4 OE $36.57 $438,840 D/D 12,000 62,425     -
   Goldsmith Mark A See Remarks   •       •      –    2025-10-17 4 AS $55.00 $550,000 D/D (10,000) 452,309 49%     
  492 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us